DNA-binding Specificity and Trans-activating Potential of the Leukemia-associated E2A-hepatic Leukemia Factor Fusion Protein

Overview

Journal Mol Cell Biol

Specialty Cell Biology

Date 1994 May 1

PMID 8164688

Citations 23

Authors

T Inaba

L H Shapiro

T Funabiki

A E Sinclair

B G Jones

R A Ashmun

A T Look

Affiliations

Soon will be listed here.

Abstract

Hybrid transcription factors, resulting from gene fusions in the wake of chromosomal translocations, have been implicated in leukemogenesis, but their precise contributions to oncogenic conversion remain unclear. The E2A-HLF fusion gene, formed by a t(17;19)(q22;p13) in childhood pro-B-cell acute lymphoid leukemia, encodes a hybrid protein that contains the trans-activation domain of E2A (E12/E47) linked to the bZIP DNA-binding and dimerization domain of hepatic leukemia factor (HLF). Here we report that both HLF and E2A-HLF bind to a 10-bp consensus sequence, 5'-GTTACGTAAT-3', with a core dyad-symmetric motif characteristic of the bZIP scissors-grip model of DNA binding. A probe containing this sequence bound chimeric E2A-HLF proteins in nuclear extracts of a leukemic cell line (UOC-B1) containing the t(17;19), as demonstrated by complexes supershifted with antibodies specific for amino-terminal epitopes of E2A or carboxyl-terminal eptiopes of HLF. E2A-HLF functioned as a potent trans activator of reporter gene expression from a plasmid that contained the consensus DNA-binding sequence. Interestingly, wild-type HLF was restricted in its capacity to act as a trans activator, functioning in human fetal kidney cells but not HepG2 hepatocarcinoma cells or NIH 3T3 mouse fibroblasts. The ability of the E2A-HLF hybrid protein to bind DNA in a sequence-specific manner and trans activate the expression of artificial reporter genes suggests that it could subvert transcriptional programs that normally control the growth, differentiation, and survival of lymphoid progenitor cells.

Citing Articles

Advances in hepatocellular carcinoma drug resistance models.

Xiang Y, Wu J, Qin H Front Med (Lausanne). 2024; 11:1437226.

PMID: 39144662 PMC: 11322137. DOI: 10.3389/fmed.2024.1437226.

Identification of Transcription Factor-Related Gene Signature and Risk Score Model for Colon Adenocarcinoma.

Lin J, Cao Z, Yu D, Cai W Front Genet. 2021; 12:709133.

PMID: 34603375 PMC: 8485095. DOI: 10.3389/fgene.2021.709133.

An updated account on molecular heterogeneity of acute leukemia.

Rahul E, Goel H, Chopra A, Ranjan A, Gupta A, Meena J Am J Blood Res. 2021; 11(1):22-43.

PMID: 33796387 PMC: 8010602.

Resistance of t(17;19)-acute lymphoblastic leukemia cell lines to multiagents in induction therapy.

Watanabe A, Inukai T, Kagami K, Abe M, Takagi M, Fukushima T Cancer Med. 2019; 8(11):5274-5288.

PMID: 31305009 PMC: 6718581. DOI: 10.1002/cam4.2356.

Critical Modulation of Hematopoietic Lineage Fate by Hepatic Leukemia Factor.

Wahlestedt M, Ladopoulos V, Hidalgo I, Sanchez Castillo M, Hannah R, Sawen P Cell Rep. 2017; 21(8):2251-2263.

PMID: 29166614 PMC: 5714592. DOI: 10.1016/j.celrep.2017.10.112.

References

Thomas P . Hybridization of denatured RNA transferred or dotted nitrocellulose paper. Methods Enzymol. 1983; 100:255-66. DOI: 10.1016/0076-6879(83)00060-9. View

Dedera D, Waller E, LeBrun D, Stevens M, Barsh G, Cleary M . Chimeric homeobox gene E2A-PBX1 induces proliferation, apoptosis, and malignant lymphomas in transgenic mice. Cell. 1993; 74(5):833-43. DOI: 10.1016/0092-8674(93)90463-z. View

Vinson C, SIGLER P, McKnight S . Scissors-grip model for DNA recognition by a family of leucine zipper proteins. Science. 1989; 246(4932):911-6. DOI: 10.1126/science.2683088. View

Henthorn P, Kiledjian M, Kadesch T . Two distinct transcription factors that bind the immunoglobulin enhancer microE5/kappa 2 motif. Science. 1990; 247(4941):467-70. DOI: 10.1126/science.2105528. View

Nourse J, Mellentin J, Galili N, Wilkinson J, Stanbridge E, Smith S . Chromosomal translocation t(1;19) results in synthesis of a homeobox fusion mRNA that codes for a potential chimeric transcription factor. Cell. 1990; 60(4):535-45. DOI: 10.1016/0092-8674(90)90657-z. View

Kamps M, Murre C, Sun X, Baltimore D . A new homeobox gene contributes the DNA binding domain of the t(1;19) translocation protein in pre-B ALL. Cell. 1990; 60(4):547-55. DOI: 10.1016/0092-8674(90)90658-2. View

Mueller C, Maire P, Schibler U . DBP, a liver-enriched transcriptional activator, is expressed late in ontogeny and its tissue specificity is determined posttranscriptionally. Cell. 1990; 61(2):279-91. DOI: 10.1016/0092-8674(90)90808-r. View

Rooney R, Raychaudhuri P, Nevins J . E4F and ATF, two transcription factors that recognize the same site, can be distinguished both physically and functionally: a role for E4F in E1A trans activation. Mol Cell Biol. 1990; 10(10):5138-49. PMC: 361186. DOI: 10.1128/mcb.10.10.5138-5149.1990. View

Kamps M, Look A, Baltimore D . The human t(1;19) translocation in pre-B ALL produces multiple nuclear E2A-Pbx1 fusion proteins with differing transforming potentials. Genes Dev. 1991; 5(3):358-68. DOI: 10.1101/gad.5.3.358. View

10.

Chittenden T, Livingston D, Kaelin Jr W . The T/E1A-binding domain of the retinoblastoma product can interact selectively with a sequence-specific DNA-binding protein. Cell. 1991; 65(6):1073-82. DOI: 10.1016/0092-8674(91)90559-h. View

11.

Shapiro L, Ashmun R, Roberts W, Look A . Separate promoters control transcription of the human aminopeptidase N gene in myeloid and intestinal epithelial cells. J Biol Chem. 1991; 266(18):11999-2007. View

12.

Cleary M . Oncogenic conversion of transcription factors by chromosomal translocations. Cell. 1991; 66(4):619-22. DOI: 10.1016/0092-8674(91)90105-8. View

13.

Drolet D, Scully K, SIMMONS D, Wegner M, Chu K, Swanson L . TEF, a transcription factor expressed specifically in the anterior pituitary during embryogenesis, defines a new class of leucine zipper proteins. Genes Dev. 1991; 5(10):1739-53. DOI: 10.1101/gad.5.10.1739. View

14.

Rabbitts T . Translocations, master genes, and differences between the origins of acute and chronic leukemias. Cell. 1991; 67(4):641-4. DOI: 10.1016/0092-8674(91)90057-6. View

15.

Lamb P, McKnight S . Diversity and specificity in transcriptional regulation: the benefits of heterotypic dimerization. Trends Biochem Sci. 1991; 16(11):417-22. DOI: 10.1016/0968-0004(91)90167-t. View

16.

Cowell I, Skinner A, Hurst H . Transcriptional repression by a novel member of the bZIP family of transcription factors. Mol Cell Biol. 1992; 12(7):3070-7. PMC: 364521. DOI: 10.1128/mcb.12.7.3070-3077.1992. View

17.

Inaba T, Roberts W, Shapiro L, Jolly K, Raimondi S, Smith S . Fusion of the leucine zipper gene HLF to the E2A gene in human acute B-lineage leukemia. Science. 1992; 257(5069):531-4. DOI: 10.1126/science.1386162. View

18.

Hunger S, Ohyashiki K, Toyama K, Cleary M . Hlf, a novel hepatic bZIP protein, shows altered DNA-binding properties following fusion to E2A in t(17;19) acute lymphoblastic leukemia. Genes Dev. 1992; 6(9):1608-20. DOI: 10.1101/gad.6.9.1608. View

19.

Kamps M, Baltimore D . E2A-Pbx1, the t(1;19) translocation protein of human pre-B-cell acute lymphocytic leukemia, causes acute myeloid leukemia in mice. Mol Cell Biol. 1993; 13(1):351-7. PMC: 358914. DOI: 10.1128/mcb.13.1.351-357.1993. View

20.

Quong M, Massari M, Zwart R, Murre C . A new transcriptional-activation motif restricted to a class of helix-loop-helix proteins is functionally conserved in both yeast and mammalian cells. Mol Cell Biol. 1993; 13(2):792-800. PMC: 358962. DOI: 10.1128/mcb.13.2.792-800.1993. View